Compare AVTX & OPRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AVTX | OPRT |
|---|---|---|
| Founded | 2011 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 248.3M | 245.8M |
| IPO Year | 2015 | 2019 |
| Metric | AVTX | OPRT |
|---|---|---|
| Price | $17.11 | $5.32 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 9 | 2 |
| Target Price | ★ $32.29 | $5.50 |
| AVG Volume (30 Days) | ★ 302.8K | 290.4K |
| Earning Date | 11-06-2025 | 02-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.66 |
| Revenue | $192,000.00 | ★ $712,623,000.00 |
| Revenue This Year | N/A | $27.11 |
| Revenue Next Year | N/A | $4.26 |
| P/E Ratio | ★ N/A | $8.00 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.39 | $3.45 |
| 52 Week High | $20.72 | $9.25 |
| Indicator | AVTX | OPRT |
|---|---|---|
| Relative Strength Index (RSI) | 48.21 | 51.18 |
| Support Level | $15.49 | $5.03 |
| Resistance Level | $18.54 | $5.40 |
| Average True Range (ATR) | 1.17 | 0.22 |
| MACD | -0.28 | -0.02 |
| Stochastic Oscillator | 44.93 | 46.38 |
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).
Oportun Financial Corp is engaged in providing financial services to people who either do not have a credit score or who may have a limited credit history. The company offers Personal Loans, Auto Loans, unsecured personal loans, and secured personal loans, and provides deposit accounts, debit card services, and other transaction services to its customers. Its product offerings include small-dollar, unsecured installment loans and other products and services.